感染与血栓形成的病理生理机制的研究进展*

侯佳 ,  洪欣 ,  洪星禹

国际老年医学杂志 ›› 2025, Vol. 46 ›› Issue (06) : 732 -736.

PDF (1117KB)
国际老年医学杂志 ›› 2025, Vol. 46 ›› Issue (06) : 732 -736. DOI: 10.3969/j.issn.1674-7593.2025.06.018
综述

感染与血栓形成的病理生理机制的研究进展*

作者信息 +

Progress on the pathophysiological mechanisms underlying infection and thrombosis

Author information +
文章历史 +
PDF (1143K)

摘要

感染与血栓形成之间存在复杂的病理生理联系, 涉及炎症反应、 凝血系统紊乱及血小板活化等多通路相互作用。 本文系统性综述感染导致血栓的机制及特点, 总结靶向感染所致血栓的预防和治疗策略, 指出感染与血栓形成在机制解析、 生物标志物开发及个体化抗凝治疗与临床管理策略中的局限。 旨在为感染相关血栓的精准防控提供理论依据。

Abstract

A complicated pathophysiological interaction exists between infection and thrombosis, involving several interrelated pathways such as inflammatory responses, coagulation problems, and platelet activation and aggregation. This systematic review consolidates existing knowledge on the causes and pathophysiological features of infection-induced thrombosis, while thoroughly assessing targeted preventive and therapeutic approaches for infection-related thromboembolic consequences. The analysis specifically identifies significant knowledge deficiencies in four research areas: mechanistic elucidation of pathogen-induced clot formation, creation of validated diagnostic biomarkers, enhancement of personalized anticoagulation therapy, and formulation of evidence-based clinical management protocols for infected populations. This review seeks to establish a theoretical framework for the meticulous management of infection-associated thrombosis and to inform the creation of pathogen-specific, risk-stratified therapeutic techniques.

关键词

血栓 / 感染 / 抗凝 / 治疗

Key words

Thrombosis / Infection / Anticoagulation / Treatment

引用本文

引用格式 ▾
侯佳,洪欣,洪星禹. 感染与血栓形成的病理生理机制的研究进展*[J]. 国际老年医学杂志, 2025, 46(06): 732-736 DOI:10.3969/j.issn.1674-7593.2025.06.018

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

van Dam L F, van Walderveen M, Kroft L, et al. Current imaging modalities for diagnosing cerebral vein thrombosis—a critical review [J]. Thromb Res, 2020, 189: 132-139.

[2]

Naghavi M, Wyde P, Litovsky S, et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E—deficient mice[J]. Circulation, 2003, 107(5): 762-768.

[3]

Tsantes A G, Parastatidou S, Tsantes E A, et al. Sepsis—induced coagulopathy: an update on pathophysiology, biomarkers, and current guidelines [J]. Life (Basel), 2023, 13(2): 350.

[4]

Murala S, Nagarajan E, Bollu P C . Infectious causes of stroke [J]. J Stroke Cerebrovasc Dis, 2022, 31(4): 106274.

[5]

Lawrence K A, Gloger E M, Pinheiro C N, et al. Associations between IL—1β, IL—6, and TNFα polymorphisms and longitudinal trajectories of cognitive function in non—demented older adults[J]. Brain Behav Immun Health, 2024, 39: 100816.

[6]

Papadopoulos A, Palaiopanos K, Björkbacka H, et al. Circulating interleukin—6 levels and incident ischemic stroke: a systematic review and meta—analysis of prospective studies [J]. Neurology, 2022, 98(10): e1002-e1012.

[7]

Yi W, Chen Q, Liu C, et al. LIPUS inhibits inflammation and catabolism through the NF—κB pathway in human degenerative nucleus pulposus cells [J]. J Orthop Surg Res, 2021, 16(1): 619.

[8]

罗羽杉, 贺娜, 赵梓棋, . 微血栓形成机制与对策新进展[J]. 国际临床研究杂志, 2022, 6(8): 170-174.

[9]

Luo Y S, He N, Zhao Z Q, et al. New advances in the mechanism and countermeasures of microthrombosis formation [J]. Int J Clin Res, 2022, 6(8): 170-174.

[10]

吴珺, 陆爱东, 张乐萍, . 儿童核心结合因子相关性急性髓系白血病疗效及预后因素分析[J]. 中华血液学杂志, 2019, 40(1): 52-57.

[11]

Wu J, Lu A D, Zhang L P, et al. Study of clinical outcome and prognosis in pediatric core binding factor—acute myeloid leukemia[J]. Chin J Hematol, 2019, 40(1): 52-57.

[12]

Chan E L, Haudek S B, Giroir B P, et al. Human coronary endothelial cell activation by endotoxin is characterized by NF—kappa B activation and TNF—alpha synthesis [J]. Shock, 2001, 16(5): 349-354.

[13]

蔡久英, 翟桂兰, 高薇, . 原发性高血压不同时间段左室重构与血管内皮损伤和炎症因子关系的研究[J]. 中国危重病急救医学, 2008, 20(12): 743-745.

[14]

Cai J Y, Zhai G L, Gao W, et al. [A study of the relationship between remodeling of left ventricle and endothelial injury and pro—inflammatory mediators in different stages of essential hypertension] [J]. Chin Crit Care Med, 2008, 20(12): 743-745.

[15]

Bloom S I, Islam M T, Lesniewski L A, et al. Mechanisms and consequences of endothelial cell senescence [J]. Nat Rev Cardiol, 2023, 20(1): 38-51.

[16]

Cervia—Hasler C, Brüningk S C, Hoch T, et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid[J]. Science, 2024, 383(6680): eadg7942.

[17]

Wójcik K, Bazan—Socha S, Celejewska—Wójcik N, et al. Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID—19 patients[J]. Thromb Res, 2023, 223: 80-86.

[18]

尹俊, 王鸿利 . 止、凝血系统中的炎症因子[J]. 诊断学理论与实践, 2009, 8(5): 556-560.

[19]

Yin J, Wang H L. Inflammatory factors in the hemostatic and coagulation system [J]. J Diagn Concepts Pract, 2009, 8(5): 556-560.

[20]

张虎, 孙婧, 李璐璐, . 纤溶酶原激活物抑制剂 1 在疾病中的研究进展[J]. 国际呼吸杂志, 2019, 39(17): 1323-1329.

[21]

Zhang H, Sun J, Li L L, et al. Research progress of plasminogen activator inhibitor—1 in several diseases [J]. Int J Respir, 2019, 39(17): 1323-1329.

[22]

张钊, 周向慧, 程志鹏, . 血小板受体 FcγRⅡA 免疫学功能研究[J]. 中华血液学杂志, 2023, 44(7): 609-614.

[23]

Zhang Z, Zhou X H, Cheng Z P, et al. Research on immunological function of platelet receptor FcγRⅡA [J]. Chin J Hematol, 2023, 44(7): 609-614.

[24]

茅敏, 李秀, 王子丹, . 血小板及其表面受体配体在脓毒症凝血病中作用的研究进展[J]. 中华临床医师杂志(电子版), 2021, 15(4): 302-307.

[25]

Mao M, Li X, Wang Z D, et al. Role of platelets and their surface receptors and ligands in septic coagulopathy [J]. Chin J Clin(Electronic Edition), 2021, 15(4): 302-307.

[26]

朱奕霖, 彭婕, 施小凤 . 整合素 αⅡbβ3 在血小板中作用的研究现状[J]. 国际输血及血液学杂志, 2023, 46(1): 26-33.

[27]

Zhu Y L, Peng J, Shi X F. Research status of integrin αⅡbβ3 in platelets [J]. Int J Blood Transfus Hematol, 2023, 46(1): 26-33.

[28]

Guo J, Cui B, Zheng J, et al. Platelet—derived microparticles and their cargos: the past, present and future[J]. Asian J Pharm Sci, 2024, 19(2): 100907.

[29]

Simak J, Gelderman M P, Yu H, et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome[J]. J Thromb Haemost, 2006, 4(6): 1296-1302.

[30]

Nadkarni G N, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID—19[J]. 2020, 76(16): 1815-1826.

[31]

Varga Z, Flammer A J, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID—19 [J]. Lancet, 2020, 395(10234): 1417-1418.

[32]

Laridan E, Martinod K, De Meyer S F . Neutrophil extracellular traps in arterial and venous thrombosis[J]. Semin Thromb Hemost, 2019, 45(1): 86-93.

[33]

Semeraro N, Ammollo C T, Semeraro F, et al. Sepsis, thrombosis and organ dysfunction [J]. Thromb Res, 2012, 129(3): 290-295.

[34]

Fitzgerald J R, Loughman A, Keane F, et al. Fibronectin—binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the Fc—gammaRIIa receptor[J]. Mol Microbiol, 2006, 59(1): 212-230.

[35]

Timsit J F, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review[J]. Intensive Care Med, 2019, 45(2): 172-189.

[36]

张丽, 于淑颖, 宁雅婷, . 全国多中心血流分离近平滑念珠菌药物敏感性和分子流行病学回顾性研究[J]. 中国真菌学杂志, 2021, 16(5): 289-295.

[37]

Zhang L, Yu S Y, Ning Y T, et al. Multicenter retrospective study on antifungal susceptibility and molecular epidemiology of Candida parapsilosis isolated from bloodstream infections in China[J]. Chin J Mycol, 2021, 16(5): 289-295.

[38]

Tang F, Zhao X L, Xu L Y, et al. Endothelial dysfunction: pathophysiology and therapeutic targets for sepsis—induced multiple organ dysfunction syndrome [J]. Biomed Pharmacother, 2024, 178: 117180.

[39]

Otto M . Staphylococcal Biofilms[J]. Microbiol Spectr, 2018, 6(4): 10.1128/microbiolspec.gpp3—0023—2018.

[40]

Kral—Pointner J B, Haider P, Szabo P L, et al. Reduced monocyte and neutrophil infiltration and activation by P—selectin/CD62P inhibition enhances thrombus resolution in mice [J]. Arterioscler Thromb Vasc Biol, 2024, 44(4): 954-968.

[41]

代荣琴, 刘玉枝, 陈洋, . 医院内静脉血栓栓塞症防治质量评价与管理指南(2022 版) 中血栓指标的解读及防治建议[J]. 护理学报, 2024, 31(13): 35-39.

[42]

Dai R Q, Liu Y Z, Chen Y, et al. Interpretation of thrombosis indicators and prevention and treatment suggestions in the Guidelines for Quality Evaluation and Management of Intravenous Thromboembolism in Hospitals(2022 Edition)[J]. J Nurs, 2024, 31(13): 35-39.

[43]

Chakraborty C, Mallick B, Bhattacharya M, et al. SARS—CoV—2 omicron spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants [J]. J Genet Eng Biotechnol, 2024, 22(1): 100347.

[44]

Hou Z, Cui C, Li Y, et al. Lattice—strain engineering for heterogenous electrocatalytic oxygen evolution reaction [J]. Adv Mater, 2023, 35(39): e2209876.

[45]

Chen A, Stecker E, A Warden B . Direct oral anticoagulant use: a practical guide to common clinical challenges [J]. J Am Heart Assoc, 2020, 9(13): e017559.

基金资助

*吉林省卫生科研人才专项项目(2024SCZ49)

AI Summary AI Mindmap
PDF (1117KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/